Marisa Haenni

Country flagFrance

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (33)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

The increase in the infection caused by Acinetobacter baumannii is sustained by the selection of distinct epidemic clonal lineages, which are frequently resistant to a broad range of antimicrobials and possess virulence traits responsible for their persistence in the contaminated environment and spread among patients. The present study aimed to perform an integrated genomic and phenotypic analysis to assess the virulence features of ST25 isolates. A. baumannii isolates assigned to the ST25 epidemic clonal lineage shared high genomic similarity and clustered in four clades (I, II, III, and IV), with clade IV further subdivided into CIVa, CIVb, CIVc, and CIVd. Capsular locus (KL) KL14 was the predominant KL type (47%). Accessory genome analysis showed the presence of tartrate metabolism genes only in CII genomes. CIVb and CIVd ST25 A. baumannii isolates showed higher ability to infect Galleria mellonella larvae than CI, CII, CIII, and CIVc isolates. Hydrogen peroxide resistance was higher in CI, CII, CIVb, and CIVd isolates compared with CIII and CIVc isolates. In desiccation survival tests, CIII, CIVb, and CIVd isolates exhibited prolonged survival. In addition, CI, CII, CIII, CIVb, and CIVd isolates showed higher serum resistance than CIVc isolates. Also, KL14 type and lipooligosaccharide outer core locus (OCL) OCL6 type isolates were significantly more resistant to oxidative stress, to desiccation, and possessed a high ability to kill G. mellonella larvae. A positive and significant correlation was found between AdeB and AdeJ efflux pump expression and hydrogen peroxide resistance. IMPORTANCE In this study, we characterized the genotypic and phenotypic features of A. baumannii strains assigned to the ST25 epidemic clonal lineage, which were isolated from humans, animals, and the environment. We found that ST25 A. baumannii isolates, irrespective of their antimicrobial resistance, showed peculiar virulence features among clades, isolates assigned to clade IVb and IVd showing the highest virulence and elevated resistance to serum and desiccation. Also, a positive significant correlation was found between the presence of KL14 and outer core locus 6 genotypes and resistance to oxidative stress, resistance to desiccation, and the ability to kill G. mellonella larvae. Phenotypic differences reflected clade identity rather than isolate origin, suggesting that specific virulence traits contribute to the environmental persistence and pathogenic potential of A. baumannii ST25 isolates.

Year:

2026

Background ‘One Health’ initiatives to tackle the rising risk of antimicrobial resistance (AMR) have flourished due to increasing detection of Enterobacterales producing extended-spectrum beta-lactamases (ESBLs) and carbapenemases (CPs). Objectives This study aimed to conduct an in-depth holistic analysis of Escherichia coli (Ec) and Klebsiella pneumoniae (Kp) isolates recovered from landfill-foraging white stork faecal samples and clinical isolates from a nearby hospital. Methods Faecal samples (n = 211) were collected from storks foraging at two landfills in Spain. Ec/Kp stork isolates were recovered on selective media and whole-genome sequencing (WGS), together with isolates obtained from the nearby hospital. These genomic data were compared with public genomes from different contexts (clinical, environmental, or animal hubs) to understand global transmission dynamics. Results A wide range of blaESBL/blapAmpC (blaCTX-M/blaSHV-12/blaDHA) were detected in 71 stork samples (33.6%), while blaCP (blaKPC/blaNDM/blaOXA-48/blaVIM) were identified in 28 (13.3%) samples. Clonal and plasmid transmissions were evidenced inside and between both landfills. Mapping against 10 624 public Ec/Kp genomes and from those of nearby hospital revealed that identical strains (<10 allelic differences with Ec-ST38/ST131 and Kp-ST512 lineages) and epidemic plasmids (full identity/coverage with IncN/blaKPC-2, IncF/blaKPC-3, IncX3/blaNDM-7, IncL/blaOXA-48) were found from clinical isolates in countries located along the storks’ migration routes. Conclusions Storks may be contaminated by bacterial isolates from a likely human origin and become non-human reservoirs of critical genes, which can be dispersed over long distances. Identifying strains/plasmids along the stork’s routes that are identical or closely related to those described here opens new perspectives for large-scale research to understand the AMR transmission dynamics.

Year:

2025

Amoxicillin-clavulanic acid (AMC) is an important antibiotic in human and veterinary medicine. However, it can select antibiotic-resistant bacteria in the gut microbiota and alter its composition. In calves, AMC can be used to treat complicated infections. The impact of AMC on the calves’ gut is unknown; thus, we analyzed the effect of a five-day AMC treatment in veal calves suffering from omphalitis. AMC-treated calves ( n = 15) and a control untreated group ( n = 15) were enrolled from two farms. Stools were collected before AMC administration (D0), one day (D6), one month (D35), and two months (D55) after AMC withdrawal. The effect of AMC treatment on gut microbiota composition and resistance gene selection was analyzed by full-length 16S rRNA operon sequencing and qPCR, respectively. Selection of Extended-Spectrum Cephalosporin-Resistant (ESC-R) Escherichia coli in calf’s fecal samples and dissemination in the farms’ environment were analyzed by cultivation and genome sequencing of isolates. After AMC treatment, alpha-diversity decreased in AMC-treated calves along with a decrease of the relative abundance of bacterial families beneficial for host health (Lachnospiraceae) and an increase of Pseudomonadota, grouping opportunistic pathogens. ESC-R E. coli carriage dynamics were different between calves sampled from each farm and seemed independent from AMC treatment. Besides, calves received other antibiotics that could have an impact on resistance selection. Certain clones of ESC-R E. coli demonstrated a widespread dissemination in the farm, both in calves hosted in distant zones and in their environment. To decrease the antibiotic resistance burden, it is essential to use antibiotics judiciously, alongside improving hygienic practices in farms. IMPORTANCE Antibiotic therapies can select resistant bacteria in the gut of treated hosts and deplete bacteria that are beneficial to the host health. Antibiotic-resistant bacteria selected in the gut of food-producing animals, like veal calves, are excreted and can then disseminate among animals, to the environment (through manure or water contamination) and to farmers who may further disseminate these organisms to other people in contact. Antibiotic resistance genes can disseminate among clones present in the gut of both animal and human hosts by horizontal gene transfer. Studying the impact of antibiotic therapies on the gut microbiota has One Health relevance. Thus, we aimed to (i) analyze the impact of AMC treatment on the selection of resistant bacteria in the calf gut and its composition and (ii) analyze the dissemination resistance in farms in order to advise on potential strategies to counteract further spread of these microorganisms.

Year:

2025

Objectives In France, a 10 year national policy to reduce antibiotic use (ABU) in animals led, respectively, to an 88% and 94% decrease in animal exposure to fluoroquinolones and third- and fourth-generation cephalosporins (3GC-4GC) between 2011 and 2021. Methods Building on national surveillance data, this study evaluated the impact of this national policy on reducing the occurrence of resistance to fluoroquinolones and 3GC-4GC in clinical Escherichia coli from young cattle and dogs and cats in France. The effect of homologous and heterologous use of antibiotics was explored using multivariate regression modelling. In addition, the time lag between implementation of national policies and subsequent reduction in antibiotic resistance (ABR) was estimated using segmented regression analysis. Results Statistical analysis of available ABU and ABR surveillance data demonstrated a significant and sustainable impact on the occurrence of resistance to fluoroquinolones in clinical E. coli (in cattle and in dogs and cats), and to a lesser extent to 3GC-4GC (in cattle). The effects were fast and observed within 1 (in cattle) or 2 years (in dogs and cats) after the implementation of the 2014 national policy targeting specifically the animals’ exposure to 3GC-4GC and fluoroquinolones. Conclusions The French 10 year national policy had a successful impact on the occurrence of resistance to fluoroquinolones and 3GC-4GC in clinical E. coli. A potential shift in ABU from the use of fluoroquinolones and 3GC-4GC to other antibiotic classes, such as trimethoprim/sulfonamides (since 2012), and penicillins and tetracyclines (since 2016), was also observed.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (63)

MARC MARENDA

senior lecturer

University of Melbourne

AUSTRALIA
View details

Paul Turner

University of Oxford

UNITED KINGDOM
View details

Ørjan Samuelsen

Professor

UiT The Arctic University of Norway

NORWAY
View details

Helena Seth-Smith

Co-Leader of Microbial Genomics Devision

University of Zurich

SWITZERLAND
View details

Nicole Stoesser

Associate Professor

University of Oxford

UNITED KINGDOM
View details

Maria Stabile

Università degli Studi di Napoli Federico II

ITALY
View details

Amy Mathers

Professor

University of Virginia

UNITED STATES
View details

Michael Bachman

Assistant Professor

University of Michigan

UNITED STATES
View details

francesco pomilio

Head of Unit

Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche

ITALY
View details

Raffaele Zarrilli

Director of the program of Epidemiology and Prevention of Health Care Associated Infections

University of Naples Federico II

ITALY
View details

Sandra Reuter

Research Group Leader

University Medical Center Freiburg

GERMANY
View details

Benjamin P. Howden

-

AUSTRALIA
View details

Koji Yahara

Group Leader

National Institute of Infectious Diseases

JAPAN
View details

Arnfinn Sundsfjord

-

NORWAY
View details

Alexandra Chiaverini

Ricercatore Sanitario (Cat. DS6) Veterinario

Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche

ITALY
View details

Sam Lipworth

University of Oxford

UNITED KINGDOM
View details

Peter Panduro Damborg

Københavns Universitet

DENMARK
View details

Andrew McArthur

Professor

McMaster University

CANADA
View details

M. Estée Török

University of Cambridge

UNITED KINGDOM
View details

Charlene Rodrigues

Assistant Professor in Microbial Genomics

London School of Hygiene & Tropical Medicine

UNITED KINGDOM
View details

Caroline Prouillac

Enseignant chercheur

VetAgro Sup

FRANCE
View details

Adrian Egli

Professor

University of Zurich

SWITZERLAND
View details

Kathryn Holt

Professor (Research)

MONASH UNIVERSITY

AUSTRALIA
View details

Leah Wendy Roberts

Queensland University of Technology

AUSTRALIA
View details

Daniela Maria Cirillo

Head of Unit

Ospedale San Raffaele

ITALY
View details

Tommaso Giani

Associate Professor

University of Florence

ITALY
View details

Glenn Browning

Director and Redmond Barry Distinguished Professor

University of Melbourne

AUSTRALIA
View details

Teresa M. Coque

-

SPAIN
View details

Eliana De Gregorio

Prof

University of Naples Federico II

ITALY
View details

Marianne Sunde

Norwegian Veterinary Institute

NORWAY
View details

Philippe Glaser

Head of research unit

Institut Pasteur

FRANCE
View details

Gian Maria Rossolini

Professor

University of Florence

ITALY
View details

Thierry Naas

Prof

Assistance Publique - Hôpitaux de Paris

FRANCE
View details

Jukka Corander

University of Oslo

NORWAY
View details

Henok Ayalew Tegegne

Baylor College of Medicine

UNITED STATES
View details

Motoyuki Sugai

-

JAPAN
View details

Susana Campino

London School of Hygiene & Tropical Medicine

UNITED KINGDOM
View details

Iren H. Löhr

Stavanger University Hospital

NORWAY
View details

D. Sassera

University of Pavia

ITALY
View details

Stephen Baker

University of Cambridge School of Clinical Medicine

UNITED KINGDOM
View details

Kelly L Wyres

MONASH UNIVERSITY

AUSTRALIA
View details

Andrea Spitaleri

Researcher

Human Technopole

ITALY
View details

Steven P Djordjevic

Research Theme Lead/Distinguished Professor

University of Sydney

AUSTRALIA
View details

Norelle Sherry

Deputy Director

University of Melbourne

AUSTRALIA
View details

Michael Brouwer

Utrecht University

NETHERLANDS
View details

MIDELET Graziella

Head of Unit

-

FRANCE
View details

Ursula Höfle

Profesor Contratado Doctor

University of Castilla-La Mancha

SPAIN
View details

Eva Heinz

Senior Lecturer

University Of Strathclyde

UNITED KINGDOM
View details

Melese Hailu Legese

Lecturer

Uppsala Universitet Uppsala biomedicinska centrum

SWEDEN
View details

Agnese LUPO

University of Lyon

FRANCE
View details

Sylvain Brisse

Université Paris Cité

FRANCE
View details

Edward Feil

Professor at Department of Life Sciences

University of Bath

UNITED KINGDOM
View details

Patrick N. A. Harris

University of Queensland

AUSTRALIA
View details

Taane Clark

Professor of Genomics and Global Health

London School of Hygiene & Tropical Medicine

UNITED KINGDOM
View details

Claire Gorrie

University of Melbourne

AUSTRALIA
View details

Carmen Torres

Professor of Biochemistry and Molecular Biology

University of La Rioja

SPAIN
View details

Joao Perdigao

Professor do ensino Básico e Secundário

Ministério da Educação

PORTUGAL
View details

Shizuo Kayama

National Institute of Infectious Diseases

JAPAN
View details

Keith Jolley

Bioinformatician

University of Oxford

UNITED KINGDOM
View details

Nicholas Thomson

Head of Programme

Wellcome Sanger Institute

UNITED KINGDOM
View details

Harry Thorpe

University of Oslo

NORWAY
View details

Nicholas Feasey

Professor

Liverpool School of Tropical Medicine

UNITED KINGDOM
View details

David Aanensen

Professor

University of Oxford

UNITED KINGDOM
View details